Use of ceftazidime in severe Gram-negative infections -- a preliminary study
- 1 January 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 8 (suppl B) , 317-321
- https://doi.org/10.1093/jac/8.suppl_b.317
Abstract
Ceftazidime was used to treat ten patients with serious Gram-negative bacillary infections. Seven patients had bronchopulmonary infections and three had urinary tract infections. In addition three patients were bacteraemic. Causative agents were: Pseudomonas aeruginosa 4, Escherichia coli 2, Proteus species 2, and Klebsiella pneumoniae 2. Doses ranged between 2 and 6 g/day. Nine out of ten patients responded favourably to ceftazidime (cure or improvement). Colonization with ceftazidimeresistant strains occurred in three cases. No evidence of nephrotoxicity was noted.Keywords
This publication has 0 references indexed in Scilit: